Pinsent Masons Guides Redx In $880M Cancer Drug Sale

By Dawood Fakhir · February 7, 2024, 4:28 PM GMT

Biotechnology company Redx Pharma PLC on Wednesday said that it has agreed to sell global rights for further development of a cancer-fighting program to Jazz Pharmaceuticals PLC for up to $880...

To view the full article, register now.